AstraZeneca (AZN.L) said on Monday two of its existing therapies were recommended for treating patients with some forms of high-risk breast cancers in the European Union, in a boost to the company's oncology portfolio.
Business
Skin Cancer Death Are Higher For Men Than Women: Sunburns Can Triple Your Risk Of Skin Cancer
July 18, 2022